10X Genomics, Inc. (TXG)
58.18
-0.92
(-1.56%)
USD |
NASDAQ |
Nov 13, 16:00
58.18
0.00 (0.00%)
After-Hours: 19:59
10X Genomics Enterprise Value : 7.271B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 7.271B |
| November 11, 2026 | 7.659B |
| November 10, 2026 | 7.771B |
| November 09, 2026 | 8.053B |
| November 06, 2026 | 7.295B |
| November 05, 2026 | 7.134B |
| November 04, 2026 | 8.378B |
| November 03, 2026 | 8.085B |
| November 02, 2026 | 7.604B |
| October 30, 2026 | 8.719B |
| October 29, 2026 | 10.22B |
| October 28, 2026 | 10.50B |
| October 27, 2026 | 9.759B |
| October 26, 2026 | 9.094B |
| October 23, 2026 | 8.908B |
| October 22, 2026 | 8.671B |
| October 21, 2026 | 9.439B |
| October 20, 2026 | 8.896B |
| October 19, 2026 | 8.690B |
| October 16, 2026 | 8.686B |
| October 15, 2026 | 9.019B |
| October 14, 2026 | 9.112B |
| October 13, 2026 | 8.940B |
| October 12, 2026 | 9.387B |
| October 09, 2026 | 10.10B |
| Date | Value |
|---|---|
| October 08, 2026 | 9.662B |
| October 07, 2026 | 9.506B |
| October 06, 2026 | 10.11B |
| October 05, 2026 | 12.35B |
| October 02, 2026 | 11.79B |
| October 01, 2026 | 11.17B |
| September 30, 2026 | 11.38B |
| September 29, 2026 | 11.26B |
| September 28, 2026 | 11.06B |
| September 25, 2026 | 10.69B |
| September 24, 2026 | 10.48B |
| September 23, 2026 | 9.379B |
| September 22, 2026 | 10.04B |
| September 21, 2026 | 9.832B |
| September 18, 2026 | 9.506B |
| September 17, 2026 | 9.555B |
| September 16, 2026 | 8.996B |
| September 15, 2026 | 9.218B |
| September 14, 2026 | 8.661B |
| September 11, 2026 | 8.463B |
| September 10, 2026 | 8.175B |
| September 09, 2026 | 8.293B |
| September 08, 2026 | 8.073B |
| September 04, 2026 | 7.689B |
| September 03, 2026 | 7.763B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 7.085B |
| Tempus AI, Inc. | 14.61B |
| Intellia Therapeutics, Inc. | 1.236B |
| Personalis, Inc. | 1.565B |
| Alamar Biosciences, Inc. (California) | 2.022B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.42M |
| Revenue (Quarterly) | 150.67M |
| Total Expenses (Quarterly) | 170.09M |
| EPS Diluted (Quarterly) | -0.1485 |
| Gross Profit Margin (Quarterly) | 75.52% |
| Profit Margin (Quarterly) | -12.89% |
| Earnings Yield | -0.89% |
| Normalized Earnings Yield | -0.9847 |